FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
WARREN, N.J., May 19, 2020 (GLOBE NEWSWIRE) -- Bellerophon Therapeutics, Inc. (Nasdaq: BLPH) (Bellerophon or the Company) today announced the pricing of offerings for an aggregate of 3,076,923 shares of its common stock at a public offering price of $13.00 per share (the Offerings). The Offerings consisted of an underwritten public offering (the Underwritten Offering) of 1,923,077 shares and a registered direct offering (the Direct Offering) of 1,153,846 shares to an institutional investor affiliated with a member of the Companys board of directors. Bellerophon has granted the underwriters of the Underwritten Offering a 30-day option to purchase up to an additional... More

